Non-invasive, home cage digital monitoring for improved safety pharmacology assessments in drug development: ICH S7A update considerations.
Saved in:
| Title: | Non-invasive, home cage digital monitoring for improved safety pharmacology assessments in drug development: ICH S7A update considerations. |
|---|---|
| Authors: | Berridge BR; B2 Pathology Solutions LLC, Cary, NC, United States of America. Electronic address: brberridge@b2pathologysolutions.com., Liu CN; Drug Safety Research and Development, Pfizer, Groton, CT, United States of America., Cherian AK; GSK, Collegeville, PA, United States of America., Lainee P; Translational Models Platform, Sanofi, Montpellier, France., DaSilva JK; Drug Safety Research and Development, Pfizer, Groton, CT, United States of America., Anger LT; Genentech, South San Francisco, CA, United States of America., Foley CM; AbbVie Inc, Chicago, IL, United States of America., Bratcher-Petersen N; The Jackson Laboratory, Bar Harbor, ME, United States of America. Electronic address: Natalie.BratcherPetersen@jax.org. |
| Source: | Journal of pharmacological and toxicological methods [J Pharmacol Toxicol Methods] 2026 Jun 01; Vol. 140, pp. 108430. Date of Electronic Publication: 2026 Jun 01. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 9206091 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-488X (Electronic) Linking ISSN: 10568719 NLM ISO Abbreviation: J Pharmacol Toxicol Methods Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1873-488X |
|---|---|
| DOI: | 10.1016/j.vascn.2026.108430 |
